Scientific article

Combining bioinformatics and MS-based proteomics: clinical implications

Published inExpert review of proteomics, vol. 11, no. 3, p. 269-284
Publication date2014

Clinical proteomics research aims at i) discovery of protein biomarkers for screening, diagnosis and prognosis of disease, ii) discovery of protein therapeutic targets for improvement of disease prevention, treatment and follow-up, and iii) development of mass spectrometry (MS)-based assays that could be implemented in clinical chemistry, microbiology or hematology laboratories. MS has been increasingly applied in clinical proteomics studies for the identification and quantification of proteins. Bioinformatics plays a key role in the exploitation of MS data in several aspects such as the generation and curation of protein sequence databases, the development of appropriate software for MS data treatment and integration with other omics data and the establishment of adequate standard files for data sharing. In this article, we discuss the main MS approaches and bioinformatics solutions that are currently applied to accomplish the objectives of clinical proteomic research.

Citation (ISO format)
ACOSTA MARTIN, Adelina Elena, LANE, Lydie. Combining bioinformatics and MS-based proteomics: clinical implications. In: Expert review of proteomics, 2014, vol. 11, n° 3, p. 269–284. doi: 10.1586/14789450.2014.900446
ISSN of the journal1478-9450

Technical informations

Creation09/15/2014 3:51:00 PM
First validation09/15/2014 3:51:00 PM
Update time03/14/2023 10:18:26 PM
Status update03/14/2023 10:18:26 PM
Last indexation01/16/2024 2:35:04 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack